Page header image

Aspirin Exacerbated Respiratory Disease (AERD): References

Global Initiative for Asthma (GINA). Global strategy for Asthma Management and Prevention. 2018. https://ginaasthma.org.

Chang JE, Chin W, Simon R. Aspirin-sensitive asthma and upper airway diseases. Am J Rhinol Allergy. 2012 Jan-Feb; 26(1):27-30.

Chang JE, White A, Simon RA, Stevenson DD. Aspirin-exacerbated respiratory disease: burden of disease. Allergy Asthma Proc. 2012 Mar-Apr;33(2):117-21. doi: 10.2500/aap.2012.33.3541.

Stevens W, Buchheit K, Cahill KN. Aspirin-exacerbated diseases: advances in asthma with nasal polyposis, urticaria, angioedema, and anaphylaxis. Curr Allergy Asthma Rep. 2015 Dec;15(12):69. doi: 10.1007/s11882-015-0569-2. PMID: 26475526.

Pongdee T. Aspirin-exacerbated respiratory disease (AERD). American Academy of allergy Asthma & Immunology. https://www.aaaai.org/conditions-and-treatments/library/asthma-library/aspirin-exacerbated-respiratory-disease. Accessed May 2018.

Bottrell J. Asthma subgroups: aspirin sensitive respiratory disease (AERD). Asthma.net. https://asthma.net/living/subgroups-aspirin-sensitive-respiratory-disease-aerd/. December 13, 2016. Accessed June 2018.

Stevens WW, Peters, AT, Hirsch AG, et al. Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease (AERD). Journal of Allergy and Clinical Immunology: In Practice, 2017-07-01, Volume 5, Issue 4, Pages 1061-1070.e3.

© 2018 Change Healthcare LLC and/or one of its subsidiaries
Page footer image